Loading…

Photolytic and Oxidative Degradation Behavior of Anticancer Drug Venetoclax: Characterization of New Degradation Products Using High Resolution Mass Spectrometry

Venetoclax ( VEN ), an anticancer drug, was subjected to photolytic and oxidative degradation studies. The comprehensive degradation profiling of VEN in both conditions was reported. All the degradation products ( DPs ) were separated on reversed phase HPLC by employing an X-Bridge C18 column with a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of analytical chemistry (New York, N.Y.) N.Y.), 2023-04, Vol.78 (4), p.522-534
Main Authors: Dhiman, Vivek, Ahirwar, Sourabh, Chaganti, Sowmya, Gananadhamu, S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Venetoclax ( VEN ), an anticancer drug, was subjected to photolytic and oxidative degradation studies. The comprehensive degradation profiling of VEN in both conditions was reported. All the degradation products ( DPs ) were separated on reversed phase HPLC by employing an X-Bridge C18 column with ammonium acetate (pH adjusted to 3.20 with acetic acid) and organic solvent mixture of methanol with acetonitrile in the ratio of 90 : 10 as mobile phase. The overall results showed that it underwent significant degradation upon exposure to light (acidic pH) and oxidative (H 2 O 2 at room temperature and 2,2-azobisisobutyronitrile at 40°C) conditions. A total of fifteen new DPs were identified with high resolution mass spectrometry data generated from liquid chromatography–high resolution mass spectrometry system. This information was used for the establishment of a complete degradation pathway of VEN. Additionally, in silico properties, viz ., absorption, distribution, metabolism, excretion and toxicity ( ADMET ), of VEN and its DPs were predicted with admetSAR software.
ISSN:1061-9348
1608-3199
DOI:10.1134/S1061934823040081